_2020091018165303jzv.jpg "Decoding The World Of ETF")
My Account
The US Food and Drug Administration on Tuesday issued a positively-worded briefing document about the Moderna COVID-19 vaccine ahead of a meeting by experts on whether to grant it emergency approval.
Follow our LIVE blog for the latest updates of the novel coronavirus pandemic
The FDA was upbeat on the vaccine, saying there were "no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization" and confirmed an overall efficacy of 94.1 percent.
Follow our full coverage of the coronavirus pandemic here.
Ideas For Profit | The maker of English Oven - Mrs Bectors IPO hits the street. Should you subscribe? Watch more 
3-Point Analysis | CPI inflation cooling off welcome, but is it enough for RBI to ease rates? Watch more 
Ola to invest Rs 2,400 crore to set up e-scooter factory in Tamil Nadu Watch more 
Explained | Will the COVID-19 vaccine rollout give a booster shot to the real estate sector? Watch more 
